OR WAIT 15 SECS
© 2021 MJH Life Sciences and Applied Clinical Trials Online. All rights reserved.
© 2021 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
August 13, 2020
Distinguishing CAR-T and CPI approaches and the clinical trial challenges and complexities associated with each.
While clinical trials are starting to make a return from COVID-19-related interruptions, cracks in their traditional operation are being exposed.
Exploring the benefits of capturing and integrating molecular biomarker data within clinical trials to build foundations for data assets.
Amid the COVID-19 pandemic, the EU is allowing trials to start before the requirements of directives dating back as far as 2001 have been met.
Firma Clinical Research CEO Michael Woods shares why COVID-19 may force greater efficiency for trial designs and greater access for trial participants.
A compilation of recent notable news developments that pertain to the clinical trials industry.
Perspectives and insights regarding regulatory considerations when planning and conducting immunotherapy studies.
The increasing need for treatments to slow the global spread of COVID-19 has prompted greater cooperation between drug regulatory authorities around the world.
If you are an organization content with patient-centric approaches, you are behind. Today it is about patient-driven drug development.
July 24, 2020
While there's been hopeful news on treatments and vaccines, sponsors should plan to discuss necessary strategies and contingencies at the outset of new studies or re-opening of halted studies during the COVID-19 pandemic.